Development and verification of an immune-related gene prognostic index for gastric cancer

Immune checkpoint inhibitor (ICI) therapy is an emerging and effective approach to the treatment of gastric cancer (GC). However, the low response rate of GC patients to ICI therapy is a major limitation of ICI therapy. We investigated the transcriptomic signature of immune genes in GC could provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Liu, Tao, Wang, Jian, Zhang, JianTao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489759/
https://www.ncbi.nlm.nih.gov/pubmed/36127384
http://dx.doi.org/10.1038/s41598-022-20007-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489759/
https://www.ncbi.nlm.nih.gov/pubmed/36127384
http://dx.doi.org/10.1038/s41598-022-20007-y

Ejemplares similares